News & Media

Press Releases

Dec 1, 2017
Amedica Receives Positive Nasdaq Listing Decision

SALT LAKE CITY, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq: AMDA) (the “Company”), an innovative biomaterial company that develops and manufactures silicon nitride as a platform for biomedical applications, announced today that on November 27, 2017, the Company received formal notice from The NASDAQ Stock Market LLC (“Nasdaq”) indicating that the Company has evidenced full compliance with all requirements for continued listing on The Nasdaq Capital Market. Accordingly, the previously-disclosed listing matter has been resolved and the Company’s securities will continue to be…

View All News

Events Calendar

Feb 21–February 24, 2018
Evidence & Technology Spine Summit

Park City, UT

View All Events

Tweets